000 01568 a2200481 4500
005 20250518095202.0
264 0 _c20210326
008 202103s 0 0 eng d
022 _a1651-226X
024 7 _a10.1080/0284186X.2020.1747638
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVan Hulle, Hans
245 0 0 _aTwo-year toxicity of hypofractionated breast cancer radiotherapy in five fractions.
_h[electronic resource]
260 _bActa oncologica (Stockholm, Sweden)
_cJul 2020
300 _a872-875 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCase-Control Studies
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aFemale
650 0 4 _aFibrosis
_xetiology
650 0 4 _aHumans
650 0 4 _aRadiation Dose Hypofractionation
650 0 4 _aRadiation Injuries
_xetiology
650 0 4 _aRetrospective Studies
650 0 4 _aTelangiectasis
_xetiology
650 0 4 _aTime Factors
700 1 _aVakaet, Vincent
700 1 _aDeckmyn, Kathleen
700 1 _aMonten, Chris
700 1 _aPaelinck, Leen
700 1 _aVan Greveling, Annick
700 1 _aPost, Giselle
700 1 _aSchoepen, Max
700 1 _aFonteyne, Arthur
700 1 _aSpeleers, Bruno
700 1 _aDeseyne, Pieter
700 1 _aMareel, Marc
700 1 _aDe Neve, Wilfried
700 1 _aVeldeman, Liv
773 0 _tActa oncologica (Stockholm, Sweden)
_gvol. 59
_gno. 7
_gp. 872-875
856 4 0 _uhttps://doi.org/10.1080/0284186X.2020.1747638
_zAvailable from publisher's website
999 _c30852872
_d30852872